发明申请
US20110152106A1 CST1, DCC1, IFITM1 OR MELK AS MARKERS FOR DIAGNOSING STOMACH CANCER
有权
CST1，DCC1，IFITM1或MELK作为诊断STOMC癌症的标记
- 专利标题： CST1, DCC1, IFITM1 OR MELK AS MARKERS FOR DIAGNOSING STOMACH CANCER
- 专利标题（中）： CST1，DCC1，IFITM1或MELK作为诊断STOMC癌症的标记
-
申请号： US12679879申请日： 2009-04-21
-
公开(公告)号： US20110152106A1公开(公告)日： 2011-06-23
- 发明人: Hee Gu Lee , Eun Young Song , Min Ah Kang , Jong Tae Kim , Eun Hwa Choi , Hyo Ran Yoon , Jae Wha Kim
- 申请人： Hee Gu Lee , Eun Young Song , Min Ah Kang , Jong Tae Kim , Eun Hwa Choi , Hyo Ran Yoon , Jae Wha Kim
- 申请人地址： KR Daejeon
- 专利权人： KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
- 当前专利权人： KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
- 当前专利权人地址： KR Daejeon
- 优先权： KR10-2008-0036867 20080421; KR10-2008-0036868 20080421; KR10-2008-0036869 20080421; KR10-2008-0036870 20080421
- 国际申请： PCT/KR09/02084 WO 20090421
- 主分类号： C40B30/00
- IPC分类号： C40B30/00 ; C07H21/00 ; C07K16/00 ; C12Q1/68 ; C40B40/06 ; C40B40/10 ; G01N33/53
摘要：
The present invention relates to a biomarker for gastric cancer, CST1 (cysteine proteinase inhibitor, type 2 family), DCC1 (Defective in sister chromatid cohesion homolog 1), IFITM1 (interferon induced transmembrane protein 1) or MELK (maternal embryonic leucine zipper kinase). More particularly, the present invention relates to a diagnostic composition for gastric cancer comprising an agent measuring the expression level of CST1, DCC1, IFITM1 or MELK, a kit comprising the composition, a method for detecting the marker, and a method for screening a therapeutic agent for gastric cancer using the marker.